Ra Pharmaceuticals (RARX) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free RARX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRA: Discount Continues To Leave Some Opportunityseekingalpha.com - January 23 at 12:36 PMImperial Petroleum, ARS Pharmaceuticals Stock, and More See Action From Activist Investorsbarrons.com - September 8 at 7:52 PMAnthera Pharmaceuticals (ANTH) Stock Dropping After Pricing Public Offeringthestreet.com - May 29 at 11:21 AMUPDATE 1-AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 bln dealmsn.com - January 10 at 12:36 PMRA Capital Closes Position in Astria Therapeutics (ATXS)247wallst.com - November 15 at 3:32 PMRARX_old Historical Datainvesting.com - August 20 at 6:18 PMPhilly-area pharma firm raises $118M for high blood pressure drugmsn.com - June 12 at 10:54 AMPhilly-area pharma firm raises $118M for high blood pressure drug for those who need extra helpmsn.com - June 8 at 9:49 AMRa Medical Systems Reports First Quarter 2022 Financial Resultsfinance.yahoo.com - May 16 at 5:54 PM Get Ra Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RARX and its competitors with MarketBeat's FREE daily newsletter. Email Address 55x Gains Instead of 9x Gains (Ad)We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.” Learn more about it by watching THIS NOW. RARX Media Mentions By Week RARX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RARX News Sentiment▼0.000.42▲Average Medical News Sentiment RARX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RARX Articles This Week▼00▲RARX Articles Average Week Get Ra Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RARX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DYN News Today ARVN News Today RYTM News Today VERA News Today GERN News Today INDV News Today CORT News Today TGTX News Today DCPH News Today PTCT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RARX) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ra Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
